Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Clene Inc. Director's Dealing 2021

Feb 4, 2021

34487_dirs_2021-02-03_b9f3cec1-7fdd-4600-975f-d26030b15d8b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Clene Inc. (CLNN)
CIK: 0001822791
Period of Report: 2021-02-01

Reporting Person: Jeong Tae Heum (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-01 Stock Options (Right to buy) $6.55 A 130000.00 Acquired 2031-02-01 Common Stock (130000.00) Direct

Footnotes

F1: This option was granted on February 1, 2021 as an option for 130,000 shares of Common Stock under the Company 2020 Stock Plan, at an exercise price of $6.55 per share. The option
vests in 24 equal installments of Common Stock on the last day of each calendar month, beginning on February 28th, 2021, until such shares are fully vested.